HEADER CELL ADHESION, STRUCTURAL PROTEIN 05-MAR-14 4PR9 TITLE HUMAN VINCULIN (RESIDUES 891-1066) IN COMPLEX WITH PIP COMPND MOL_ID: 1; COMPND 2 MOLECULE: VINCULIN; COMPND 3 CHAIN: A, B, C, D, E, F; COMPND 4 FRAGMENT: C-TERMINAL DOMAIN (UNP RESIDUES 891-1066 OF ISOFORM 1); COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: VCL; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PGEX 6P1 KEYWDS 5-HELIX BUNDLE, CYTOSKELETAL PROTEIN, LIPIDS, CELL ADHESION, KEYWDS 2 STRUCTURAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR K.CHINTHALAPUDI,E.S.RANGARAJAN,D.PATIL,T.IZARD REVDAT 2 20-SEP-23 4PR9 1 REMARK SEQADV REVDAT 1 10-DEC-14 4PR9 0 JRNL AUTH K.CHINTHALAPUDI,E.S.RANGARAJAN,D.PATIL,T.IZARD JRNL TITL MECHANISM AND FUNCTION OF LIPID-DIRECTED OLIGOMERIZATION OF JRNL TITL 2 VINCULIN JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 3.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.4 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.17 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 19178 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.206 REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.250 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.040 REMARK 3 FREE R VALUE TEST SET COUNT : 967 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 3.20 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 3.37 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.68 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2738 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2356 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2594 REMARK 3 BIN R VALUE (WORKING SET) : 0.2340 REMARK 3 BIN FREE R VALUE : 0.2632 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.26 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 144 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7994 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 140 REMARK 3 SOLVENT ATOMS : 40 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 111.6 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 142.0 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 9.72180 REMARK 3 B22 (A**2) : 9.72180 REMARK 3 B33 (A**2) : -19.44370 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 1.018 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.509 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.954 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.932 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 8211 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 11033 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 3179 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 209 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 1153 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 8211 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 1173 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 9535 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.14 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 1.81 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 3.27 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4PR9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-MAR-14. REMARK 100 THE DEPOSITION ID IS D_1000085123. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-AUG-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX300HS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AUTOPROC, SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19218 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.200 REMARK 200 RESOLUTION RANGE LOW (A) : 88.836 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 7.400 REMARK 200 R MERGE (I) : 0.05300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.37 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MIR REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1RKE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.89 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.45 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 12% PEG3350, 2% TRYPTONE, 0.05 M REMARK 280 HEPES, PH 7.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 1 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -Y,-X,-Z+1/3 REMARK 290 5555 -X+Y,Y,-Z+2/3 REMARK 290 6555 X,X-Y,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 127.18133 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 63.59067 REMARK 290 SMTRY1 4 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 63.59067 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 127.18133 REMARK 290 SMTRY1 6 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN A 1066 REMARK 465 TYR C 1065 REMARK 465 GLN C 1066 REMARK 465 GLY E 891 REMARK 465 GLU E 892 REMARK 465 TYR E 1065 REMARK 465 GLN E 1066 REMARK 465 GLY F 891 REMARK 465 GLU F 892 REMARK 465 VAL F 893 REMARK 465 SER F 1045 REMARK 465 ILE F 1046 REMARK 465 LYS F 1047 REMARK 465 ILE F 1048 REMARK 465 ARG F 1049 REMARK 465 THR F 1050 REMARK 465 ASP F 1051 REMARK 465 VAL F 1059 REMARK 465 ALA F 1060 REMARK 465 LYS F 1061 REMARK 465 THR F 1062 REMARK 465 TYR F 1065 REMARK 465 GLN F 1066 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PHE B1054 CG CD1 CD2 CE1 CE2 CZ REMARK 470 PHE E1054 CG CD1 CD2 CE1 CE2 CZ REMARK 470 PHE F1054 CG CD1 CD2 CE1 CE2 CZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLU E 932 NH2 ARG E 935 1.72 REMARK 500 O ARG D 987 OG1 THR D 990 1.93 REMARK 500 CD ARG D 1049 OD1 ASP D 1051 2.10 REMARK 500 O PRO D 989 OG SER D 992 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A1048 -165.69 -111.17 REMARK 500 ARG A1049 58.12 -101.19 REMARK 500 THR A1050 51.95 39.83 REMARK 500 TRP A1058 79.48 -107.55 REMARK 500 GLU B 892 65.15 -119.65 REMARK 500 GLU C 892 161.79 -46.70 REMARK 500 TRP C1058 78.29 -106.57 REMARK 500 TRP D1058 79.52 -106.32 REMARK 500 LEU E1006 -72.58 -144.24 REMARK 500 SER E1012 155.79 -49.82 REMARK 500 TRP E1058 78.36 -105.75 REMARK 500 CYS F 972 -163.01 -128.92 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 LYS B 1061 THR B 1062 -146.52 REMARK 500 TRP F 912 SER F 913 -141.25 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 PIO A 1101 REMARK 610 PIO B 1101 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PIO A 1101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PIO B 1101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 1102 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL C 1101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PIO E 1101 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1RKE RELATED DB: PDB REMARK 900 HUMAN VINCULIN HEAD (1-258) IN COMPLEX WITH HUMAN VINCULIN TAIL REMARK 900 (879-1066) DBREF 4PR9 A 891 1066 UNP P18206 VINC_HUMAN 891 1066 DBREF 4PR9 B 891 1066 UNP P18206 VINC_HUMAN 891 1066 DBREF 4PR9 C 891 1066 UNP P18206 VINC_HUMAN 891 1066 DBREF 4PR9 D 891 1066 UNP P18206 VINC_HUMAN 891 1066 DBREF 4PR9 E 891 1066 UNP P18206 VINC_HUMAN 891 1066 DBREF 4PR9 F 891 1066 UNP P18206 VINC_HUMAN 891 1066 SEQADV 4PR9 ALA A 1060 UNP P18206 ARG 1060 ENGINEERED MUTATION SEQADV 4PR9 ALA B 1060 UNP P18206 ARG 1060 ENGINEERED MUTATION SEQADV 4PR9 ALA C 1060 UNP P18206 ARG 1060 ENGINEERED MUTATION SEQADV 4PR9 ALA D 1060 UNP P18206 ARG 1060 ENGINEERED MUTATION SEQADV 4PR9 ALA E 1060 UNP P18206 ARG 1060 ENGINEERED MUTATION SEQADV 4PR9 ALA F 1060 UNP P18206 ARG 1060 ENGINEERED MUTATION SEQRES 1 A 176 GLY GLU VAL ILE ASN GLN PRO MET MET MET ALA ALA ARG SEQRES 2 A 176 GLN LEU HIS ASP GLU ALA ARG LYS TRP SER SER LYS GLY SEQRES 3 A 176 ASN ASP ILE ILE ALA ALA ALA LYS ARG MET ALA LEU LEU SEQRES 4 A 176 MET ALA GLU MET SER ARG LEU VAL ARG GLY GLY SER GLY SEQRES 5 A 176 THR LYS ARG ALA LEU ILE GLN CYS ALA LYS ASP ILE ALA SEQRES 6 A 176 LYS ALA SER ASP GLU VAL THR ARG LEU ALA LYS GLU VAL SEQRES 7 A 176 ALA LYS GLN CYS THR ASP LYS ARG ILE ARG THR ASN LEU SEQRES 8 A 176 LEU GLN VAL CYS GLU ARG ILE PRO THR ILE SER THR GLN SEQRES 9 A 176 LEU LYS ILE LEU SER THR VAL LYS ALA THR MET LEU GLY SEQRES 10 A 176 ARG THR ASN ILE SER ASP GLU GLU SER GLU GLN ALA THR SEQRES 11 A 176 GLU MET LEU VAL HIS ASN ALA GLN ASN LEU MET GLN SER SEQRES 12 A 176 VAL LYS GLU THR VAL ARG GLU ALA GLU ALA ALA SER ILE SEQRES 13 A 176 LYS ILE ARG THR ASP ALA GLY PHE THR LEU ARG TRP VAL SEQRES 14 A 176 ALA LYS THR PRO TRP TYR GLN SEQRES 1 B 176 GLY GLU VAL ILE ASN GLN PRO MET MET MET ALA ALA ARG SEQRES 2 B 176 GLN LEU HIS ASP GLU ALA ARG LYS TRP SER SER LYS GLY SEQRES 3 B 176 ASN ASP ILE ILE ALA ALA ALA LYS ARG MET ALA LEU LEU SEQRES 4 B 176 MET ALA GLU MET SER ARG LEU VAL ARG GLY GLY SER GLY SEQRES 5 B 176 THR LYS ARG ALA LEU ILE GLN CYS ALA LYS ASP ILE ALA SEQRES 6 B 176 LYS ALA SER ASP GLU VAL THR ARG LEU ALA LYS GLU VAL SEQRES 7 B 176 ALA LYS GLN CYS THR ASP LYS ARG ILE ARG THR ASN LEU SEQRES 8 B 176 LEU GLN VAL CYS GLU ARG ILE PRO THR ILE SER THR GLN SEQRES 9 B 176 LEU LYS ILE LEU SER THR VAL LYS ALA THR MET LEU GLY SEQRES 10 B 176 ARG THR ASN ILE SER ASP GLU GLU SER GLU GLN ALA THR SEQRES 11 B 176 GLU MET LEU VAL HIS ASN ALA GLN ASN LEU MET GLN SER SEQRES 12 B 176 VAL LYS GLU THR VAL ARG GLU ALA GLU ALA ALA SER ILE SEQRES 13 B 176 LYS ILE ARG THR ASP ALA GLY PHE THR LEU ARG TRP VAL SEQRES 14 B 176 ALA LYS THR PRO TRP TYR GLN SEQRES 1 C 176 GLY GLU VAL ILE ASN GLN PRO MET MET MET ALA ALA ARG SEQRES 2 C 176 GLN LEU HIS ASP GLU ALA ARG LYS TRP SER SER LYS GLY SEQRES 3 C 176 ASN ASP ILE ILE ALA ALA ALA LYS ARG MET ALA LEU LEU SEQRES 4 C 176 MET ALA GLU MET SER ARG LEU VAL ARG GLY GLY SER GLY SEQRES 5 C 176 THR LYS ARG ALA LEU ILE GLN CYS ALA LYS ASP ILE ALA SEQRES 6 C 176 LYS ALA SER ASP GLU VAL THR ARG LEU ALA LYS GLU VAL SEQRES 7 C 176 ALA LYS GLN CYS THR ASP LYS ARG ILE ARG THR ASN LEU SEQRES 8 C 176 LEU GLN VAL CYS GLU ARG ILE PRO THR ILE SER THR GLN SEQRES 9 C 176 LEU LYS ILE LEU SER THR VAL LYS ALA THR MET LEU GLY SEQRES 10 C 176 ARG THR ASN ILE SER ASP GLU GLU SER GLU GLN ALA THR SEQRES 11 C 176 GLU MET LEU VAL HIS ASN ALA GLN ASN LEU MET GLN SER SEQRES 12 C 176 VAL LYS GLU THR VAL ARG GLU ALA GLU ALA ALA SER ILE SEQRES 13 C 176 LYS ILE ARG THR ASP ALA GLY PHE THR LEU ARG TRP VAL SEQRES 14 C 176 ALA LYS THR PRO TRP TYR GLN SEQRES 1 D 176 GLY GLU VAL ILE ASN GLN PRO MET MET MET ALA ALA ARG SEQRES 2 D 176 GLN LEU HIS ASP GLU ALA ARG LYS TRP SER SER LYS GLY SEQRES 3 D 176 ASN ASP ILE ILE ALA ALA ALA LYS ARG MET ALA LEU LEU SEQRES 4 D 176 MET ALA GLU MET SER ARG LEU VAL ARG GLY GLY SER GLY SEQRES 5 D 176 THR LYS ARG ALA LEU ILE GLN CYS ALA LYS ASP ILE ALA SEQRES 6 D 176 LYS ALA SER ASP GLU VAL THR ARG LEU ALA LYS GLU VAL SEQRES 7 D 176 ALA LYS GLN CYS THR ASP LYS ARG ILE ARG THR ASN LEU SEQRES 8 D 176 LEU GLN VAL CYS GLU ARG ILE PRO THR ILE SER THR GLN SEQRES 9 D 176 LEU LYS ILE LEU SER THR VAL LYS ALA THR MET LEU GLY SEQRES 10 D 176 ARG THR ASN ILE SER ASP GLU GLU SER GLU GLN ALA THR SEQRES 11 D 176 GLU MET LEU VAL HIS ASN ALA GLN ASN LEU MET GLN SER SEQRES 12 D 176 VAL LYS GLU THR VAL ARG GLU ALA GLU ALA ALA SER ILE SEQRES 13 D 176 LYS ILE ARG THR ASP ALA GLY PHE THR LEU ARG TRP VAL SEQRES 14 D 176 ALA LYS THR PRO TRP TYR GLN SEQRES 1 E 176 GLY GLU VAL ILE ASN GLN PRO MET MET MET ALA ALA ARG SEQRES 2 E 176 GLN LEU HIS ASP GLU ALA ARG LYS TRP SER SER LYS GLY SEQRES 3 E 176 ASN ASP ILE ILE ALA ALA ALA LYS ARG MET ALA LEU LEU SEQRES 4 E 176 MET ALA GLU MET SER ARG LEU VAL ARG GLY GLY SER GLY SEQRES 5 E 176 THR LYS ARG ALA LEU ILE GLN CYS ALA LYS ASP ILE ALA SEQRES 6 E 176 LYS ALA SER ASP GLU VAL THR ARG LEU ALA LYS GLU VAL SEQRES 7 E 176 ALA LYS GLN CYS THR ASP LYS ARG ILE ARG THR ASN LEU SEQRES 8 E 176 LEU GLN VAL CYS GLU ARG ILE PRO THR ILE SER THR GLN SEQRES 9 E 176 LEU LYS ILE LEU SER THR VAL LYS ALA THR MET LEU GLY SEQRES 10 E 176 ARG THR ASN ILE SER ASP GLU GLU SER GLU GLN ALA THR SEQRES 11 E 176 GLU MET LEU VAL HIS ASN ALA GLN ASN LEU MET GLN SER SEQRES 12 E 176 VAL LYS GLU THR VAL ARG GLU ALA GLU ALA ALA SER ILE SEQRES 13 E 176 LYS ILE ARG THR ASP ALA GLY PHE THR LEU ARG TRP VAL SEQRES 14 E 176 ALA LYS THR PRO TRP TYR GLN SEQRES 1 F 176 GLY GLU VAL ILE ASN GLN PRO MET MET MET ALA ALA ARG SEQRES 2 F 176 GLN LEU HIS ASP GLU ALA ARG LYS TRP SER SER LYS GLY SEQRES 3 F 176 ASN ASP ILE ILE ALA ALA ALA LYS ARG MET ALA LEU LEU SEQRES 4 F 176 MET ALA GLU MET SER ARG LEU VAL ARG GLY GLY SER GLY SEQRES 5 F 176 THR LYS ARG ALA LEU ILE GLN CYS ALA LYS ASP ILE ALA SEQRES 6 F 176 LYS ALA SER ASP GLU VAL THR ARG LEU ALA LYS GLU VAL SEQRES 7 F 176 ALA LYS GLN CYS THR ASP LYS ARG ILE ARG THR ASN LEU SEQRES 8 F 176 LEU GLN VAL CYS GLU ARG ILE PRO THR ILE SER THR GLN SEQRES 9 F 176 LEU LYS ILE LEU SER THR VAL LYS ALA THR MET LEU GLY SEQRES 10 F 176 ARG THR ASN ILE SER ASP GLU GLU SER GLU GLN ALA THR SEQRES 11 F 176 GLU MET LEU VAL HIS ASN ALA GLN ASN LEU MET GLN SER SEQRES 12 F 176 VAL LYS GLU THR VAL ARG GLU ALA GLU ALA ALA SER ILE SEQRES 13 F 176 LYS ILE ARG THR ASP ALA GLY PHE THR LEU ARG TRP VAL SEQRES 14 F 176 ALA LYS THR PRO TRP TYR GLN HET PIO A1101 38 HET PIO B1101 37 HET GOL B1102 6 HET GOL C1101 6 HET PIO E1101 47 HET GOL F1101 6 HETNAM PIO [(2R)-2-OCTANOYLOXY-3-[OXIDANYL-[(1R,2R,3S,4R,5R,6S)-2, HETNAM 2 PIO 3,6-TRIS(OXIDANYL)-4,5-DIPHOSPHONOOXY-CYCLOHEXYL]OXY- HETNAM 3 PIO PHOSPHORYL]OXY-PROPYL] OCTANOATE HETNAM GOL GLYCEROL HETSYN PIO DIOCTANOYL L-ALPHA-PHOSPHATIDYL-D-MYO-INOSITOL 4,5- HETSYN 2 PIO DIPHOSPHATE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 7 PIO 3(C25 H49 O19 P3) FORMUL 9 GOL 3(C3 H8 O3) FORMUL 13 HOH *40(H2 O) HELIX 1 1 ASN A 895 ARG A 910 1 16 HELIX 2 2 ASN A 917 VAL A 937 1 21 HELIX 3 3 GLY A 940 GLY A 942 5 3 HELIX 4 4 THR A 943 GLN A 971 1 29 HELIX 5 5 ASP A 974 LEU A 1006 1 33 HELIX 6 6 SER A 1012 ALA A 1044 1 33 HELIX 7 7 ASN B 895 ARG B 910 1 16 HELIX 8 8 ASN B 917 ARG B 935 1 19 HELIX 9 9 GLY B 940 GLY B 942 5 3 HELIX 10 10 THR B 943 GLN B 971 1 29 HELIX 11 11 ASP B 974 THR B 1004 1 31 HELIX 12 12 SER B 1012 ALA B 1044 1 33 HELIX 13 13 ASN C 895 ARG C 910 1 16 HELIX 14 14 ASN C 917 VAL C 937 1 21 HELIX 15 15 GLY C 940 GLY C 942 5 3 HELIX 16 16 THR C 943 GLN C 971 1 29 HELIX 17 17 ASP C 974 GLU C 986 1 13 HELIX 18 18 ARG C 987 LEU C 1006 1 20 HELIX 19 19 SER C 1012 ALA C 1044 1 33 HELIX 20 20 ASN D 895 ARG D 910 1 16 HELIX 21 21 ASN D 917 ARG D 938 1 22 HELIX 22 22 GLY D 939 GLY D 942 5 4 HELIX 23 23 THR D 943 GLN D 971 1 29 HELIX 24 24 ASP D 974 ARG D 987 1 14 HELIX 25 25 ARG D 987 LEU D 1006 1 20 HELIX 26 26 SER D 1012 ALA D 1044 1 33 HELIX 27 27 ASN E 895 ARG E 910 1 16 HELIX 28 28 ASN E 917 ARG E 938 1 22 HELIX 29 29 GLY E 940 GLY E 942 5 3 HELIX 30 30 THR E 943 GLN E 971 1 29 HELIX 31 31 ASP E 974 GLU E 986 1 13 HELIX 32 32 ARG E 987 MET E 1005 1 19 HELIX 33 33 SER E 1012 ALA E 1044 1 33 HELIX 34 34 ASN F 895 ARG F 910 1 16 HELIX 35 35 ASN F 917 ARG F 938 1 22 HELIX 36 36 GLY F 940 GLY F 942 5 3 HELIX 37 37 THR F 943 GLN F 971 1 29 HELIX 38 38 ARG F 976 GLU F 986 1 11 HELIX 39 39 ARG F 987 LEU F 1006 1 20 HELIX 40 40 SER F 1012 ALA F 1044 1 33 CISPEP 1 PRO F 1063 TRP F 1064 0 -0.03 SITE 1 AC1 6 SER A 914 LYS A 915 LYS A1061 HOH A1206 SITE 2 AC1 6 LYS B 915 LYS B1061 SITE 1 AC2 6 LYS B 944 ARG B 945 HOH B1218 LYS C 915 SITE 2 AC2 6 GOL C1101 LYS D 915 SITE 1 AC3 1 LYS B 915 SITE 1 AC4 1 PIO B1101 SITE 1 AC5 10 LYS D 944 ARG D 945 THR D1004 SER E 913 SITE 2 AC5 10 SER E 914 LYS E 915 LYS E1061 SER F 914 SITE 3 AC5 10 LYS F 915 ARG F1057 CRYST1 102.579 102.579 190.772 90.00 90.00 120.00 P 32 1 2 36 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009749 0.005628 0.000000 0.00000 SCALE2 0.000000 0.011257 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005242 0.00000